Artículos de revistas sobre el tema "Kappa free light chains"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Kappa free light chains".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Schwenkenbecher, Philipp, Franz Konen, Ulrich Wurster, Konstantin Jendretzky, Stefan Gingele, Kurt-Wolfram Sühs, Refik Pul, Torsten Witte, Martin Stangel y Thomas Skripuletz. "The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis". International Journal of Molecular Sciences 19, n.º 12 (29 de noviembre de 2018): 3796. http://dx.doi.org/10.3390/ijms19123796.
Dul, J. L., S. Aviel, J. Melnick y Y. Argon. "Ig light chains are secreted predominantly as monomers." Journal of Immunology 157, n.º 7 (1 de octubre de 1996): 2969–75. http://dx.doi.org/10.4049/jimmunol.157.7.2969.
Ambrosino, D. M., M. V. Kanchana, N. R. Delaney y R. W. Finberg. "Human B cells secrete predominantly lambda L chains in the absence of H chain expression." Journal of Immunology 146, n.º 2 (15 de enero de 1991): 599–602. http://dx.doi.org/10.4049/jimmunol.146.2.599.
Richter, Alex G., Stephen Harding, Aarnoud Huissoon, Mark Drayson y Guy Pratt. "Multiple Myeloma with Monoclonal Free IgG3 Heavy Chains and Free Kappa Light Chains". Acta Haematologica 123, n.º 3 (2010): 158–61. http://dx.doi.org/10.1159/000292899.
Arneth, Borros y Jörg Kraus. "The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis". Medicina 58, n.º 11 (24 de octubre de 2022): 1512. http://dx.doi.org/10.3390/medicina58111512.
Ramsden, DB. "Multiple sclerosis: assay of free immunoglobulin light chains". Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 54, n.º 1 (28 de septiembre de 2016): 5–13. http://dx.doi.org/10.1177/0004563216652175.
Vinayek, Namita, Goetz H. Kloecker y Beth C. Riley. "Multiple Myeloma with Secretory and Non-Secretory Biclonal Gammopathy". Blood 118, n.º 21 (18 de noviembre de 2011): 5092. http://dx.doi.org/10.1182/blood.v118.21.5092.5092.
Abbi, Kamal Kant Singh, Guido J. Tricot, Margarida Silverman, Kalyan Nadiminti y Matthew Krasowski. "Potential Pitfalls of Serum Free Light Chain Analysis to Assess Treatment Response for Multiple Myeloma". Blood 126, n.º 23 (3 de diciembre de 2015): 5308. http://dx.doi.org/10.1182/blood.v126.23.5308.5308.
Rudick, Richard A., Adam Pallant, Jean M. Bidlack y Robert M. Herndon. "Free kappa light chains in multiple sclerosis spinal fluid". Annals of Neurology 20, n.º 1 (julio de 1986): 63–69. http://dx.doi.org/10.1002/ana.410200111.
Pratt, G., A. Richter, A. Huisoon, M. Drayson y S. Harding. "A177 Multiple Myeloma with Monoclonal Free IgG3 Heavy Chains and Free Kappa Light Chains". Clinical Lymphoma and Myeloma 9 (febrero de 2009): S30—S31. http://dx.doi.org/10.1016/s1557-9190(11)70494-2.
Lee, Won S. y Gurmukh Singh. "Serum Free Light Chain Assay in Monoclonal Gammopathic Manifestations". Laboratory Medicine 50, n.º 4 (8 de abril de 2019): 381–89. http://dx.doi.org/10.1093/labmed/lmz007.
Richter, Alex G., Stephen Harding, Steve Rimmer, Guy Pratt, Aarnoud Huissoon y Mark Drayson. "Biclonal Multiple Myeloma with Monoclonal Free IgG3 Heavy Chain and kappa Free Light Chains." Blood 110, n.º 11 (16 de noviembre de 2007): 4768. http://dx.doi.org/10.1182/blood.v110.11.4768.4768.
Mehta, P. D., S. D. Cook, P. K. Coyle, R. A. Troiano, C. S. Constantinescu y A. M. Rostami. "Free light chains in multiple sclerosis urine". Multiple Sclerosis Journal 4, n.º 3 (junio de 1998): 254–56. http://dx.doi.org/10.1177/135245859800400331.
Kaplan, Batia, Esther Ganelin-Cohen, Sizilia Golderman y Avi Livneh. "Diagnostic utility of kappa free light chains in multiple sclerosis". Expert Review of Molecular Diagnostics 19, n.º 4 (27 de febrero de 2019): 277–79. http://dx.doi.org/10.1080/14737159.2019.1586535.
Markowitz, Glen S., Raymond S. Flis, Neeraja Kambham y Vivette D. D'Agati. "Fanconi syndrome with free kappa light chains in the urine". American Journal of Kidney Diseases 35, n.º 4 (abril de 2000): 777–81. http://dx.doi.org/10.1016/s0272-6386(00)70032-1.
Yap, Clementine YF, Pey Wah Wong y Tar Choon Aw. "Free Kappa and Lambda Light Chains in Plasma Cell Dyscrasias". Proceedings of Singapore Healthcare 20, n.º 1 (marzo de 2011): 64–66. http://dx.doi.org/10.1177/201010581102000111.
Singh, Gurmukh. "Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas". Laboratory Medicine 50, n.º 2 (13 de noviembre de 2018): 189–93. http://dx.doi.org/10.1093/labmed/lmy067.
Augustson, Bradley M., Steven D. Reid, Graham P. Mead, Mark T. Drayson, J. Anthony Child y Arthur R. Bradwell. "Serum Free Light Chain Levels in Asymptomatic Myeloma." Blood 104, n.º 11 (16 de noviembre de 2004): 4880. http://dx.doi.org/10.1182/blood.v104.11.4880.4880.
Levinson, Stanley S. "kappa/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias". Clinical Chemistry 37, n.º 6 (1 de junio de 1991): 1122–26. http://dx.doi.org/10.1093/clinchem/37.6.1122.
Šegulja, Dragana, Danica Matišić, Karmela Barišić y Dunja Rogić. "Verification study of free light chains assays on reagent-optimized analysers". Biochemia medica 29, n.º 3 (15 de octubre de 2019): 579–86. http://dx.doi.org/10.11613/bm.2019.030709.
Singh, Gurmukh. "Serum and Urine Protein Electrophoresis and Serum-Free Light Chain Assays in the Diagnosis and Monitoring of Monoclonal Gammopathies". Journal of Applied Laboratory Medicine 5, n.º 6 (1 de noviembre de 2020): 1358–71. http://dx.doi.org/10.1093/jalm/jfaa153.
Saadeh, Ruba S., Sandra C. Bryant, Andrew McKeon, Brian Weinshenker, David L. Murray, Sean J. Pittock y Maria Alice V. Willrich. "CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis". Mayo Clinic Proceedings 97, n.º 4 (abril de 2022): 738–51. http://dx.doi.org/10.1016/j.mayocp.2021.09.014.
Süße, Marie, Fritz Feistner, Matthias Grothe, Matthias Nauck, Alexander Dressel y Malte Johannes Hannich. "Free light chains kappa can differentiate between myelitis and noninflammatory myelopathy". Neurology - Neuroimmunology Neuroinflammation 7, n.º 6 (18 de septiembre de 2020): e892. http://dx.doi.org/10.1212/nxi.0000000000000892.
Bayart, J. L., N. Muls y V. van Pesch. "Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?" Acta Neurologica Scandinavica 138, n.º 4 (13 de junio de 2018): 352–58. http://dx.doi.org/10.1111/ane.12969.
Čabarkapa, Velibor, Zoran Stošić, Mirjana Đerić, Ljiljana Vučurević-Ristić y Mirjana Drljača. "The Importance of Free Light Chains of Immunoglobulins Determination in Serum". Journal of Medical Biochemistry 26, n.º 4 (1 de diciembre de 2007): 269–73. http://dx.doi.org/10.2478/v10011-007-0032-6.
Treger, Rebecca, Kathleen Hutchinson, Andrew Bryan y Chihiro Morishima. "Lambda monoclonal free light chain abnormalities detected by a serum immunofixation electrophoresis assay are underrepresented by quantitative serum free light chain results". American Journal of Clinical Pathology 156, Supplement_1 (1 de octubre de 2021): S13—S14. http://dx.doi.org/10.1093/ajcp/aqab189.023.
Levinson, S. S. y D. F. Keren. "Free light chains of immunoglobulins: clinical laboratory analysis". Clinical Chemistry 40, n.º 10 (1 de octubre de 1994): 1869–78. http://dx.doi.org/10.1093/clinchem/40.10.1869.
Sidana, Surbhi, Lisa Rybicki, Frederic J. Reu y Thomas Daly. "High Serum Free Kappa Chains Are Frequently Missed By Serum Immunofixation". Blood 124, n.º 21 (6 de diciembre de 2014): 5708. http://dx.doi.org/10.1182/blood.v124.21.5708.5708.
Einarsson Long, Thorir, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, Ingigerdur Sverrisdottir, Elias Eythorsson, Olafur Indridason, Runolfur Palsson et al. "Revised Definition of Free Light Chains in Serum and Light Chain Monoclonal Gammopathy of Undetermined Significance: Results of the Istopmm Study". Blood 142, Supplement 1 (28 de noviembre de 2023): 535. http://dx.doi.org/10.1182/blood-2023-188547.
Zeldenrust, Steven R., Ellen W. Blanco y Karl A. Nath. "Amyloidogenic lambda Light Chain Renal Toxicity: Oxidative Stress Implicated." Blood 110, n.º 11 (16 de noviembre de 2007): 3531. http://dx.doi.org/10.1182/blood.v110.11.3531.3531.
Bradwell, Arthur R., Jean Garbincius y Earle W. Holmes. "Serum Free Kappa to Free Lambda Ratios as an Adjunct to Serum Protein Electrophoresis for the Detection of Monoclonal Proteins in the Serum." Blood 104, n.º 11 (16 de noviembre de 2004): 4856. http://dx.doi.org/10.1182/blood.v104.11.4856.4856.
Moesbauer, Ulrike, Heike Schieder, Helmut Renges, Francis Ayuk, Axel Zander y Nicolaus Kröger. "Serum Free Light Chain [FLC] Assay in Multiple Myeloma Patients Who Achieved Negative Immunofixation after Allogeneic Stem Cell Transplantation." Blood 106, n.º 11 (16 de noviembre de 2005): 2023. http://dx.doi.org/10.1182/blood.v106.11.2023.2023.
Long, Thorir E., Olafur S. Indridason, Runolfur Palsson, Stephen Harding, Ola Landgren y Sigurdur Y. Kristinsson. "The Effect of Kidney Function on Reference Intervals of Serum-Free Light Chains and Free Light Chain Kappa/Lambda Ratio". Journal of the American Society of Nephrology 32, n.º 10S (octubre de 2021): 743. http://dx.doi.org/10.1681/asn.20213210s1743b.
Rudick, RA, SV Medendorp, M. Namey, S. Boyle y J. Fischer. "Multiple sclerosis progression in a natural history study: Predictive value of cerebrospinal fluid free kappa light chains". Multiple Sclerosis Journal 1, n.º 3 (noviembre de 1995): 150–55. http://dx.doi.org/10.1177/135245859500100303.
Hess, P. P., W. Mastropaolo, G. D. Thompson y S. S. Levinson. "Interference of polyclonal free light chains with identification of Bence Jones proteins". Clinical Chemistry 39, n.º 8 (1 de agosto de 1993): 1734–38. http://dx.doi.org/10.1093/clinchem/39.8.1734.
Ganta, Nagapratap, Varsha Gupta, Fnu Anamika, Akshit Chitkara, Sheilabi Seeburun y Ruchi Bhatt. "Lymphoplasmacytic Lymphoma: An Atypical Presentation with IgG Monoclonal Gammopathy". Blood 142, Supplement 1 (28 de noviembre de 2023): 4425. http://dx.doi.org/10.1182/blood-2023-191167.
Nakaki, T., R. J. Deans y A. S. Lee. "Enhanced transcription of the 78,000-dalton glucose-regulated protein (GRP78) gene and association of GRP78 with immunoglobulin light chains in a nonsecreting B-cell myeloma line (NS-1)". Molecular and Cellular Biology 9, n.º 5 (mayo de 1989): 2233–38. http://dx.doi.org/10.1128/mcb.9.5.2233-2238.1989.
Nakaki, T., R. J. Deans y A. S. Lee. "Enhanced transcription of the 78,000-dalton glucose-regulated protein (GRP78) gene and association of GRP78 with immunoglobulin light chains in a nonsecreting B-cell myeloma line (NS-1)." Molecular and Cellular Biology 9, n.º 5 (mayo de 1989): 2233–38. http://dx.doi.org/10.1128/mcb.9.5.2233.
Berek, Klaus, Gabriel Bsteh, Michael Auer, Franziska Di Pauli, Astrid Grams, Dejan Milosavljevic, Paulina Poskaite et al. "Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity". Neurology - Neuroimmunology Neuroinflammation 8, n.º 4 (28 de mayo de 2021): e1005. http://dx.doi.org/10.1212/nxi.0000000000001005.
Presslauer, Stefan, Dejan Milosavljevic, Wolfgang Huebl, Silvia Parigger, Gabriele Schneider-Koch y Thomas Bruecke. "Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS". PLoS ONE 9, n.º 2 (25 de febrero de 2014): e89945. http://dx.doi.org/10.1371/journal.pone.0089945.
Vecchio, D., I. Crespi, E. Virgilio, P. Naldi, M. P. Campisi, R. Serino, U. Dianzani, G. Bellomo, R. Cantello y C. Comi. "Kappa free light chains could predict early disease course in multiple sclerosis". Multiple Sclerosis and Related Disorders 30 (mayo de 2019): 81–84. http://dx.doi.org/10.1016/j.msard.2019.02.001.
Fong, S., P. P. Chen, T. A. Gilbertson, R. I. Fox, J. H. Vaughan y D. A. Carson. "Structural similarities in the kappa light chains of human rheumatoid factor paraproteins and serum immunoglobulins bearing a cross-reactive idiotype." Journal of Immunology 135, n.º 3 (1 de septiembre de 1985): 1955–60. http://dx.doi.org/10.4049/jimmunol.135.3.1955.
Sarris, Katerina, Dimitrios Maltezas, Efstathios Koulieris, Vassiliki Bartzis, Tatiana Tzenou, Sotirios Sachanas, Eftychia Nikolaou et al. "Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia". Advances in Hematology 2013 (2013): 1–7. http://dx.doi.org/10.1155/2013/359071.
Shammo, Jamile M., Agne Paner, MV Ramana Reddy, Rachel L. Mitchell y Parameswaran Venugopal. "A Striking Reduction of Monoclonal Protein in a Patient with Concurrent Plasma Cell Dyscrasia and CMML-2, after Treatment with Rigosertib (01910.Na)". Blood 126, n.º 23 (3 de diciembre de 2015): 5362. http://dx.doi.org/10.1182/blood.v126.23.5362.5362.
Lee, Won Sok y Gurmukh Singh. "Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies". Journal of Clinical Medicine Research 10, n.º 7 (2018): 562–69. http://dx.doi.org/10.14740/jocmr3383w.
Giussani, Marta, Chiara Maura Ciniselli, Alessandra Macciotta, Rossella Panella, Paolo Verderio, Chiara Bonini y Daniele Morelli. "κ and λ urine free light chains: a new method for quantification". Tumori Journal 106, n.º 6 (20 de enero de 2020): 457–63. http://dx.doi.org/10.1177/0300891619898533.
Lee, Won y Gurmukh Singh. "Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Underproduction and Underdetection of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies". American Journal of Clinical Pathology 150, suppl_1 (21 de septiembre de 2018): S145—S146. http://dx.doi.org/10.1093/ajcp/aqy112.346.
Vavrova, Jaroslava, Bedrich Friedecky, Milos Tichy, Magdalena Holeckova, Vladimir Maisnar y Roman Hajek. "The Evaluation of Light Chains USING ELISA Method". Blood 112, n.º 11 (16 de noviembre de 2008): 5147. http://dx.doi.org/10.1182/blood.v112.11.5147.5147.
Чурко, А. А. y А. Ш. Румянцев. "Free Light Chains of Immunoglobulins as a Biomarker of Glomerulopathies". Juvenis Scientia, n.º 3 (30 de junio de 2023): 42–50. http://dx.doi.org/10.32415/jscientia_2023_9_3_42-50.
Duell, Frida, Björn Evertsson, Faiez Al Nimer, Åsa Sandin, Daniel Olsson, Tomas Olsson, Mohsen Khademi, Max Albert Hietala, Fredrik Piehl y Magnus Hansson. "Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS". Neurology - Neuroimmunology Neuroinflammation 7, n.º 4 (11 de junio de 2020): e775. http://dx.doi.org/10.1212/nxi.0000000000000775.